1. Proteoglycans were extracted from sclera with 4M-guanidine hydrochloride in the presence of proteinase inhibitors and purified by ion-exchange chromatography and density-gradient centrifugation. 2. The entire proteoglycan pool was characterized by compositional analyses and by specific chemical (periodate oxidation) and enzymic (chondroitinases) degradations. The glycan moieties of the molecules were exclusively galactosaminoglycans (dermatan sulphate-chondroitin sulphate co-polymers). In addition, the preparations contained small amounts of oligosaccharides. 3. The scleral proteodermatan sulphates were fractionated into one larger (I) and one smaller (II) component by gel chromatography. Proteoglycan I was eluted in a more excluded position on gel chromatography in 0.5 M-sodium acetate than in 4.0M-guanidine hydrochloride. Reduced and alkylated proteoglycan I was eluted in the same position (in 0.5 M-sodium acetate) as was the starting material (in 4.0M-guanidine hydrochloride).
1. Proteoglycans were extracted from sclera with 4M-guanidine hydrochloride in the presence of proteinase inhibitors and purified by ion-exchange chromatography and density-gradient centrifugation. 2. The entire proteoglycan pool was characterized by compositional analyses and by specific chemical (periodate oxidation) and enzymic (chondroitinases) degradations. The glycan moieties of the molecules were exclusively galactosaminoglycans (dermatan sulphate-chondroitin sulphate co-polymers). In addition, the preparations contained small amounts of oligosaccharides. 3. The scleral proteodermatan sulphates were fractionated into one larger (I) and one smaller (II) component by gel chromatography. Proteoglycan I was eluted in a more excluded position on gel chromatography in 0.5 M-sodium acetate than in 4.0M-guanidine hydrochloride. Reduced and alkylated proteoglycan I was eluted in the same position (in 0.5 M-sodium acetate) as was the starting material (in 4.0M-guanidine hydrochloride).
The elution position of proteoglycan II was the same in both solvents. Proteoglycans I and II had s°values of 2.8 x 10-13 and 2.2 x 10-13 s respectively in 6.0M-guanidine hydrochloride. 4. The two proteoglycans differed with respect to the nature of the protein core and the co-polymeric structure of their side chains. Also proteoglycan I contained more side chains than did proteoglycan II. The dermatan sulphate side chains of proteoglycan I were D-glucuronic acid-rich (80%), whereas those of proteoglycan II contained equal amounts of D-glucuronic acid and L-iduronic acid. Furthermore, the co-polymeric features of the side chains of proteoglycans I and II were different. The protein core of proteoglycan I was of larger size than that of proteoglycan II. The latter had an apparent molecular weight of 46000 (estimated by sodium dodecyl sulphate/ polyacrylamide-gel electrophoresis), whereas the former was >100000. In addition, the amino-acid composition of the two core preparations was different. 5. As proteoglycan I altered its elution position on gel chromatography in 4M-guanidine hydrochloride compared with 0.5 M-sodium acetate it is proposed that a change in conformation or a disaggregation took place. If the latter hypothesis is favoured, aggregation may be due to self-association or mediated by an extrinsic molecule, e.g. hyaluronic acid.
Fibrous connective tissues contain an abundance of collagen fibres and, in the interfibrillar matrix, characteristic macromolecular glycoconjugates, which include dermatan sulphate proteoglycans. These molecules are difficult to extract quantitatively in an undegraded state. By extraction with urea at elevated temperatures Toole & Lowther (1965 , 1968 succeeded in isolating proteodermatan sulphates from heart valves, skin and tendon. By a similar approach Obrink (1972) prepared a proteoglycan from pig skin. Proteoglycans have also been extracted from tendon, arterial wall and sclera using 4M-guanidine (Anderson, 1975 Vol. 193 1975; Radhakrishnamurthy et al., 1977) . More recently, Damle et al. (1979) separated pig skin proteoglycan into one proteochondroitin sulphate and one proteodermatan sulphate. These studies have demonstrated that dermatan sulphate is covalently linked to a non-collagenous protein.
By the introduction of efficient procedures for the extraction of fibrous connective tissues (Antonopoulos et al., 1974) and the utilization of proteinase inhibitors (Oegema et al., 1975) it became possible to isolate proteoglycans quantitatively from such tissues in a more native state. The present study is concerned with the extraction, purification and characterization of proteoglycans from bovine sclera. Preliminary reports have been published (C6ster & Fransson, 1975 (C6ster & Fransson, , 1976 (8 M) were passed through a mixed anion-cation exchange resin to remove traces of cyanate immediately before use. Dithiothreitol ('for biochemistry') was bought from Merck, Darmstadt, Germany. All other chemials were analytical grade.
Analytical methods
Hexosamine was quantified by a modified ElsonMorgan procedure (Antonopoulos et al., 1964) . Hexose was estimated by the method of Goa (1955) . Hexuronic acid was determined by the carbazole-borate method (Bitter & Muir, 1962) and protein by the method of Lowry et al. (1951) . Automated versions of these methods were also employed (Heinegard, 1973) .
Amino acids, glucosamine and galactosamine were estimated by using a Durrum automatic amino-acid analyser. Hydrolysis was performed (under argon) in 6M-HCI at 1100C for 24h (for amino acids) or in 8M-HCl at 950C for 3h (for hexosamines). Norleucine was used as the internal standard. The amounts of cysteine and cystine were determined as cysteic acid (on the amino-acid analyser) after oxidation with performic acid (Moore, 1963) . Hydroxyproline was quantified by the method of Stegemann & Stalder (1967) .
Neutral sugars were determined by g.l.c. of their alditol acetates after hydrolysis in 2M-trifluoroacetic acid at 1000C for 4h under N2 (Axelsson & Heinegard, 1975 (Anseth, 1961) .
Polyacrylamide-gel electrophoresis was conducted on 5 or 8% (w/v) gels in 0.1% sodium dodecyl sulphate by the procedure of Neville (1971 Density-gradient centrifugation A 4 M-guanidine hydrochloride/0.05 M-sodium acetate, pH 5.8/CsCl solution containing proteinase inhibitors with a starting density of 1.30g/ml was prepared and the crude proteoglycan preparation (5 mg/ml) was dissolved in this solution. Centrifugation was performed in an MSE Superspeed 65 centrifuge fitted with an 8 x 25 ml angle rotor at 10°C and 34000rev./min for 48h. Tubes were emptied (2 ml fractions) with the aid of an MSE tube piercer. The densities of the fractions were determined with a 200,u1 pipette as pycnometer. Uronic acid was estimated directly on the fractions and protein was estimated by measuring the A280 after diluting 10-fold with water. Material was recovered by dialysis against several changes of water followed by freeze-drying. Final purification and fractionation of the proteoglycan was performed by gel chromatography on a column (16 mm x 1300 mm) of Sepharose CL4B, which was eluted with 0.5 Msodium acetate, pH 7.0, or 4M-guanidine hydrochloride/0.05 M-Tris/HCl, pH 7.0, at a rate of 13 ml/ h; fraction size, 3.5 ml.
Preparation ofthe protein core
Isolation of the protein core of the proteoglycans was accomplished by digestion with chondroitinase-ABC followed by gel chromatography (see above). Keiser & Hatcher (1977) claim that commercial chondroitinase-ABC preparations contain small amounts of proteinases. Therefore, chondroitinase-ABC digestions of proteoglycans were carried out on a time scale of 3, 6, 12, 24 and 48h. In addition, digestions were performed in the presence of 2 mM-di-isopropyl fluorophosphate.
Results

Isolation and characterization of scleral proteoglycans
Analyses of tissue extracts and residues by ECTEOLA-cellulose chromatography of papain digests (Anseth, 1961) indicated that at least 85% of the tissue glycosaminoglycans were extracted by 4M-guanidine hydrochloride. The crude proteoglycan preparation (2M-NaCl fraction from DEAEcellulose chromatography) was obtained in a yield of approx. 80%. This fraction was further purified by density-gradient centrifugation in 4M-guanidine hydrochloride/CsCl. Fractions 1-5 from the bottom of the tube (densities>1.30g/ml) corresponded to 90% of the hexuronic acid content of the material subjected to centrifugation. The purified proteoglycan contained 16% hexuronic acid and 50% protein. No hydroxyproline was detected. The overall yield after these steps was approx. 60%.
The purified proteoglycan was characterized by gel chromatography on Sepharose 2B and 4B (Figs. la and lb). Two proteoglycan components were observed, the larger of which was included on Sepharose 2B (Fig. la) but partially excluded from Sepharose 4B (Fig. lb) . To demonstrate the proteoglycan nature of these components, chromatography was performed after release of the glycan side chains by alkali (Fig. lc) or by papain digestion (Fig. ld) . The polysaccharides were eluted in a more retarded position than the proteoglycans. The results suggest that the smallest proteoglycans (V, = 40-55 ml in Fig. lb ) contained very few glycan side chains.
The carbohydrate portion of the proteoglycan consisted of 87% glycosaminoglycan and 13% small neutral oligosaccharides (ECTEOLA-cellulose chromatography of papain digests and expressed as hexosamine). In the glycosaminoglycan portion the hexosamines were exclusively galactosamine. Thus no heparan sulphate could be present. To ascertain the uronic acid composition the galactosamino- glycan side chains were treated with periodate at pH3.0 and 4°C (selective oxidation of L-iduronic acid) followed by scission in alkali (Fig. 2) . As most of the material was eluted in a more retarded position compared with the untreated chains it may be concluded that all side chains contained L-iduronic acid and the original proteoglycan may be classified Effluent volume (ml) Fig. 2 . Gel chromatography on Sephadex G-200 of papain-digested proteoglycans before (a) and after (b) periodate oxidation-alkaline elimination
The purified proteoglycan was digested with papain (see the Experimental section) and chromatographed (a). The glycosaminoglycan-peptides were subsequently oxidized with periodate (L-iduronic acid residues), cleaved in alkali and chromatographed (b). Column size, 9mm x 1400mm; eluent, 0.5M-sodium acetate, pH 5.0; rate, 5 ml/h; analysis, uronic acid.
as a dermatan sulphate proteoglycan. This was confirmed by chondroitinase-ABC digestion of the side chains. They were completely degraded to disaccharides (see below).
Subfractionation ofthe proteoglycan As indicated above ( Fig. 1 ) the purified scleral proteoglycan was heterogeneous in size and two subpopulations could be discerned. On chromatography on Sepharose CL4B in 0.5M-sodium acetate (Fig. 3a) the larger proteoglycan subpopulation was almost entirely excluded (proteoglycan I). However, on gel chromatography in 4 M-guanidine hydrochloride (Fig. 3b) proteoglycan I was partially included in the gel, whereas the position of proteoglycan II was unchanged. The two proteoglycan subfractions were isolated by preparative gel chromatography (see the Experimental section) either in 0.5 M-sodium acetate (Fig. 3a) or in 4 M-guanidine hydrochloride (Fig. 3b) . In both cases the yields were 40 and 60% respectively, on a w/w basis. The chemical composition was also the same whether the separation was carried out in acetate or guanidine (see below). Rechromatography of proteoglycan I isolated as in Fig. 3(a) on the same column eluted with 4M-guanidine hydrochloride produced the profile of a partially included proteoglycan (results not shown). Conversely, rechromatography ofproteoglycan I isolated as shown in Fig. 3(b) on the same column but in acetate resulted in exclusion of the material (as shown in Fig. 3a) . Proteoglycan subfraction II was eluted in the same position in both solvents. After reduction and alkylation of the proteoglycans, fraction I was partially included in the gel (Fig. 3c) (Heinegard, 1973) , dermatan sulphates with L-iduronic acid content should give lower colour yield in the automated procedure as the boiling time is shorter (7-8min versus 20min). As shown in Table 1 (Fig. 3) either in 0.5M-sodium acetate, pH 7.0, or in 4M-guanidine hydrochloride, pH 7.0. In both cases, the yields of proteoglycans I and II were 40 and 60% respectively on a w/w basis. The fractions were digested with papain and the liberated carbohydrate prosthetic groups were separated Into glycopeptides and glycosaminoglycans (expressed as the percentage of total hexosamine). The uronic acid composition (expressed as the percentage of total uronic acid) was determined after chondroitinase-AC (D-glucuronic acid) and chondroitinase-ABC digestions (L-iduronic acid + D-glucuronic acid) followed by quantification of unsaturated glycuronosyl residues. L-Iduronic acid content = total uronic acid -D-glucuronic acid. Protein (Folin) Selective periodate oxidation of L-iduronic acid residues in the glycan side chains followed by scission in alkali and gel chromatography afforded the elution profile shown in Fig. 4 . In accordance with the high content of D-glucuronic acid, chains from proteoglycan I were moderately degraded (Fig.  4a) . The degradation products that were excluded from the gel (fraction 1) were further degraded with chondroitinase AC (Fig. 4b) . The vast majority of the material was degraded to disaccharides. The periodate-degradation products that were partially included in the gel (fraction 2 in Fig. 4a ) yielded both disaccharides and oligosaccharides on chondroitinase-AC digestion (Fig. 4c) . These oligosaccharides represent sequences where the L-iduronic Effluent volume (ml) Fig. 4 . Gel chromatography on Sephadex G-50 ofdegradation products derivedfrom the dermatan sulphate side chains of(a-c) proteoglycan I and (d-f) proteoglycan II Proteoglycan subfractions I and II (Fig. 3a) were digested with papain (see the Experimental section) and the liberated side chains (isolated by ECTEOLA-cellulose chromatography) were subsequently degraded by periodate oxidation-alkaline elimination (a and d). The excluded and the partially included degradation products (fractions 1 and 2 respectively) were separately digested with chondroitinase-AC and re-chromatographed on the same column (the results for fraction 1 are shown in b and e and those for fraction 2 in c andf). Column size 8mm x 1500mm; eluent, 0.2 M-pyridine/acetate, pH 5.0; rate, 6 ml/h; analysis, carbazole.
acid residues are 0-sulphated . Thus the side chains of proteoglycan I are characterized by the presence of large block regions composed of D-glucuronic acid-containing repeats. Periodate oxidation-alkaline degradation of the side chains of proteoglycan II produced largely oligosaccharide fragments (Fig. 4d) . The fragments eluted with the void volume (fraction 1) contained an appreciable quantity of chondroitinase-AC-resistant material (Fig. 4e) . The main oligosaccharide fraction obtained after periodate oxidation (fraction 2 in Although the side chains of proteoglycan II afforded large amounts of saccharides containing periodateresistant uronic acids (Fig. 4d) a considerable proportion of these saccharides contained both L-iduronic acid 0-sulphate and D-glucuronic acid (Fig. 4f) . The corresponding saccharide fraction from proteoglycan I (fraction 2 in Fig. 4a) contained largely D-glucuronic acid residues (Fig. 4c) .
The amino-acid compositions of the parent scleral proteoglycan, the subfractions I and II and proteoglycans prepared from skin, cornea and cartilage by other workers are given in Table 3 . In proteoglycan I the serine, threonine, glutamate, proline, alanine and glycine contents were higher, whereas the aspartate, isoleucine, leucine and lysine contents were lower than in proteoglycan II; methionine was only found in the latter species, whereas cysteine was present in both.
The protein cores of the two subpopulations were prepared by chondroitinase-ABC digestion followed by preparative gel chromatography. As shown in Fig. 5 the protein core of proteoglycan I (Fig. 5a ) was of a larger size than that of proteoglycan II (Fig.   5b ). On polyacrylamide-gel electrophoresis intact proteoglycan II had a polydisperse appearance with an apparent average molecular weight of 85 000 (results not shown). After chondroitinase-ABC digestion one distinct band was observed with an apparent molecular weight of 46000. The results were the same whether the chondroitinase-ABC digestion was carried out for 3 h or 48 h or if di-isopropyl fluorophosphate was present in the digestion mixture. Thus our preparation of chondroitinase-ABC did not seem to contain any proteinases active on the core protein. Identification of the core protein of proteoglycan I after gel electrophoresis was difficult owing to low affinity for the staining reagent. When large amounts of material were applied, core preparation I did not seem to penetrate into a 5% gel, suggesting a molecular weight >100000.
Discussion
Dermatan sulphate-containing proteoglycans have been isolated from heart valves, skin, tendon, sclera and arterial wall. The proteoglycans of the arterial wall are generally of higher buoyant density and higher carbohydrate content than those of the other tissues. Furthermore, the arterial wall (R. Kapoor, C. F. Phelps, L. Coster & L.-A. Fransson, unpublished work) and skin (Damle et al., 1979) (Fig. 3a) were digested with chondroitinase-ABC and the protein core and liberated disaccharides were separated on the same column as in Fig. 1 contain separate proteochondroitin sulphate and proteodermatan sulphate species. The proteoglycans of sclera, heart valves, tendon *and skin resemble each other with respect to protein content and amino-acid composition. Attempts to determine the molecular weight of proteodermatan sulphates have yielded values ranging from approx. 105 (Toole & Lowther, 1968; Anderson, 1975; Damle et al., 1979) to 3 x 106 (6brink, 1972 Hascall & Sajdera, 1970) . The 2.1 S scleral proteoglycan (II) contained 60% protein and the apparent molecular weight of the core protein was 46000. Thus a molecular weight of 80000 may be calculated for the intact proteoglycan II. This is to be compared with a value of 85000 obtained for the intact material by gel electrophoresis. It was not possible to obtain a molecular-weight estimate for the 2.8 S proteoglycan (I) in gel electrophoresis. Results of gel chromatography and ultracentrifugation of proteoglycan I show that it is larger than proteoglycan II, but still considerably smaller than cartilage proteoglycan (cf. S values above; see also Figs. 1 and 5).
Both proteoglycans from sclera seemed to carry two types of carbohydrate side groups, i.e. mannose-and glucosamine-rich oligosaccharides and galactosaminoglycans. These side groups must be located at the s'ame protein core, as digestion of the glycans by chrondroitinase-ABC alters the elution position in gel chromatography (Fig. 5 ) and the mobility in sodium dodecyl sulphate/polyacrylamide-gel electrophoresis of the entire material, including the anthrone-positive components. Furthermore, only one component could be detected on electrophoresis.
The two scleral proteoglycans are both exclusively proteodermatan sulphates. However, the two subfractions differed with respect to the co-polymeric structure of their dermatan sulphate side chains. The results obtained here are slightly at variance with those reported by Antonopoulos et al. (1974) . We obtain two proteoglycan subpopulations instead of four, our fractions contain more protein and we do not find any chondroitin sulphate proper in the material. This can be ascribed to differences in the methods ofextraction and analyses. In the present study the use of proteinase inhibitors minimize degradation and therefore decreases the heterogeneity and increases the protein content of the preparation. In the previous study (Antonopoulos et al., 1974) the method used to quantify chondroitin sulphate and dermatan sulphate did not distinguish between D-glucuronic acid-rich co-polymeric dermatan sulphate and chondroitin sulphate proper (Fransson et al., 1970) . The dermatan sulphate side chains of proteoglycan I were largely composed of D-glucuronic acid-N-acetylgalactosamine sulphate repeats. The L-iduronic acid containing units were few (20%), and occasionally arranged in short sequences intercalated between short sequences containing D-glucuronic acid. Although the dermatan sulphate side chains of proteoglycan II contained a large proportion of short sequences with D-glucuronic acid, the intercalated L-iduronic acid-containing repeats often carried an ester sulphate on the uronic acid moiety. The two proteodermatan sulphates described in the present report contained markedly different protein cores, as indicated by distinctly different amino-acid composition and molecular size (Fig. 5) . Proteoglycan I, which carried more side chains than did proteoglycan II (60 and 45% carbohydrate respectively) had a higher serine content. As shown previously dermatan sulphate chains are linked to protein via the sequence D-glucuronic acid-D-galactose-D-galactose-D-xylose-serine (Fransson, 1968; Stern et al., 1971) . In general, proteoglycan I, which had more chondroitin sulphate-like side chains, had an amino-acid composition similar to the chondroitin sulphate-rich proteoglycans from skin (Damle et al., 1979) and cartilage (Heinegird, 1972) . In contrast, proteoglycan II, which had a higher protein content than did proteoglycan I, was more akin to the protein-rich comeal proteokeratan sulphates described by Axelsson & Heinegird (1975) .
As proteoglycan I altered its elution position on gel chromatography in 4M-guanidine hydrochloride compared with 0.5 M-sodium acetate it is proposed that a change in conformation or a disaggregation took place. We favour the latter hypothesis, as proteoglycan I appears smaller in 4.0M-guanidine and after reduction and alkylation. A conformational change induced by guanidine or by the cleavage of disulphide bonds might rather expand the molecule. Proteoglycan II showed no aggregation phenomenon under the present conditions. The aggregation seen with proteoglycan I must be due to self-association or mediated by an extrinsic molecule. Self association may be mediated via the side chains and/or protein core in three different ways, & Hascall, 1974) . The finding that reduction and alkylation abolished aggregation might suggest that the protein core was involved. The same treatment of cartilage proteoglycan abolishes the interaction with hyaluronate (Hardingham & Muir, 1974; Heinegird & Hascall, 1974) . The scleral proteoglycan was of rather low buoyant density. Therefore it cannot be excluded that endogenous hyaluronic acid was present in the purified material. As the proteoglycans were purified by ion-exchange chromatography and density-gradient centrifugation in a dissociative medium the presence of an aggregating protein seems rather unlikely.
Self association of proteoglycan I could be mediated by the dermatan sulphate side chains. Free dermatan sulphate chains from various sources self-associate (Fransson, 1976) . These species of dermatan sulphate possess alternating or mixed sequences of L-iduronic acid-and D-glucuronic acid-containing repeats. Non-aggregating chains lack this feature and contain considerable amounts of O-sulphated L-iduronic acid residues (Fransson & Coster, 1979) . At present one cannot definitely distinguish between the various possibilities for multimerization of proteodermatan sulphate. Any explanation, however, must take into account the distinct chemical differences between scleral proteodermatan sulphates I and II, both with regard to the nature of the protein core and the co-polymeric features of their side chains.
